1998
DOI: 10.1002/(sici)1521-3765(19981102)4:11<2091::aid-chem2091>3.0.co;2-3
|View full text |Cite
|
Sign up to set email alerts
|

Designing Novel RNA Binders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0
4

Year Published

1999
1999
2003
2003

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 90 publications
(15 citation statements)
references
References 27 publications
0
11
0
4
Order By: Relevance
“…11À15 Much less is known, however, about the modulation of enzymatic activity by low molecular weight ligands. 16 The rapid generation of molecular diversity via combinatorial approaches provides new opportunities to further our understanding of RNA recognition. Large-scale investigations are hampered, however, by the inherent experimental difficulties associated with evaluating ribozyme function.…”
Section: Introductionmentioning
confidence: 99%
“…11À15 Much less is known, however, about the modulation of enzymatic activity by low molecular weight ligands. 16 The rapid generation of molecular diversity via combinatorial approaches provides new opportunities to further our understanding of RNA recognition. Large-scale investigations are hampered, however, by the inherent experimental difficulties associated with evaluating ribozyme function.…”
Section: Introductionmentioning
confidence: 99%
“…Their promiscuous binding to non-ribosomal RNAs and/or membrane components may be related to the multiple therapeutic side effects exhibited by these compounds [47][48][49]. Aminoglycosides bind to and inhibit the function of a wide range of unrelated RNAs with moderate activities (IC 50 ¼ 0.1-100 mM) [23,50]. Aminoglycosides do, however, show excellent specificity for RNA over DNA (Section 2.5.3).…”
Section: Ligand Specificitymentioning
confidence: 99%
“…In most cases, however, the binding stoichiometry of the inhibitor is not known, so its affinity to the RRE is evaluated by measuring the concentration of inhibitor needed to displace half of the Rev peptide from the RRE (defined as the ligand's IC 50 value). [34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50]. The peptide RevFl is used for fluorescence-based assays and is succinylated at its N-terminus, amidated at its C-terminus, and contains a four-alanine spacer to fluorescein.…”
Section: Fluorescence Anisotropymentioning
confidence: 99%
“…3 Aminoglycosides, a clinically important class of antibiotics, act by binding to bacterial RNA. 4 High affinity binding of different aminoglycosides to specific sites in larger RNA molecules including ribosomal RNA, the hammerhead ribozyme 5 or smaller RNAs such as 16S rRNA and 23S rRNA has been extensively studied. 6,7 The interaction of aminoglycoside analogs with RNA has provided a detailed understanding of critical interactions responsible for selective aminoglycoside-RNA binding.…”
mentioning
confidence: 99%
“…6,7 The interaction of aminoglycoside analogs with RNA has provided a detailed understanding of critical interactions responsible for selective aminoglycoside-RNA binding. 4,8,9 Since electrostatic interactions play a key role in aminoglycoside-RNA recognition, the introduction of additional amine groups significantly improved binding while decreasing selectivity. Screening of a series of aminoglycoside analogs against the 16S rRNA, revealed a 1,3-hydroxyamine binding motif with micromolar affinity.…”
mentioning
confidence: 99%